|
gptkbp:instanceOf
|
gptkb:drug
gptkb:isoquinoline_sulfonamide
|
|
gptkbp:approvedBy
|
gptkb:Japan
|
|
gptkbp:ATCCode
|
C04AX28
|
|
gptkbp:CASNumber
|
103745-39-7
|
|
gptkbp:chemicalFormula
|
C14H17N3O2S
|
|
gptkbp:compatibleWith
|
gptkb:United_States
|
|
gptkbp:developedBy
|
gptkb:Japan
|
|
gptkbp:discoveredBy
|
gptkb:Asahi_Kasei
|
|
gptkbp:hasSMILES
|
C1CNCCN(C1)S(=O)(=O)C2=CC=CC3=CN=CC=C32
|
|
gptkbp:hasUNII
|
8X7Q0I84HV
|
|
gptkbp:IUPACName
|
5-(1,4-diazepan-1-ylsulfonyl)isoquinoline
|
|
gptkbp:mechanismOfAction
|
gptkb:Rho_kinase_inhibitor
|
|
gptkbp:molecularWeight
|
291.37 g/mol
|
|
gptkbp:PubChem_CID
|
gptkb:CHEMBL1423
60714
D01536
DB04707
|
|
gptkbp:routeOfAdministration
|
intravenous
|
|
gptkbp:sideEffect
|
nausea
headache
hypotension
liver enzyme elevation
|
|
gptkbp:synonym
|
Fasudil hydrochloride
HA-1077
|
|
gptkbp:target
|
Rho-associated protein kinase (ROCK)
|
|
gptkbp:usedFor
|
treatment of cerebral vasospasm
treatment of pulmonary hypertension
|
|
gptkbp:bfsParent
|
gptkb:ROCK_(Rho-associated_kinase)
|
|
gptkbp:bfsLayer
|
7
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
fasudil
|